Sulfuric Acid

Sulfuric Acid

SCHEMBL1318239

N=C(N)N.N=C(N)N.O=S(=O)(O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 4/20 0.59
KDM4E B2RXH2 2/20 0.59
CYP2C19 P33261 2/20 0.59
CYP2D6 P10635 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
CA5A P35218 3/20 0.55
CA5B Q9Y2D0 3/20 0.55
TSHR P16473 4/20 0.46
CA2 P00918 3/20 0.46
CA1 P00915 2/20 0.46
CA4 P22748 2/20 0.46
CA6 P23280 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
NT5E P21589 1/20 0.46
TDP1 Q9NUW8 2/20 0.36
ALOX15 P16050 1/20 0.36
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28148838 1.00 BLM (0.59) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL170524 1.00
Sulfuric Acid SCHEMBL5014255 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL9703220 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL6018155 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL9797137 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL4162831 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL4167092 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL22127325 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1
Sulfuric Acid SCHEMBL7093064 0.96 BLM (0.56) BLMKDM4ECYP2C19CYP2D6NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4657589-A1 ELECTROLYTE ADDITIVE FOR ZN-MNO2 BATTERIES Centre National de la Recherche Scientifique (FR) 2025-12-03 EP claimed
EP-4640204-A2 HAIR COSMETIC COMPOSITION Kao Corporation (JP) 2025-10-29 EP claimed
EP-3831362-B1 HAIR COSMETIC COMPOSITION KAO CORP (JP) 2025-10-15 EP claimed
WO-2025099347-A1 METHOD FOR OBTAINING COMPOSITES BASED ON G-C3N4/ZNO FUNCTIONALISED WITH CYANAMIDE GROUPS (ZNNCN) UNIVERSIDAD DE GRANADA (ES) 2025-05-15 WO claimed
US-12287558-B2 Nonlinear optical crystal of guanidinium tetrafluoroborate, preparation method and use thereof XINJIANG TECHNICAL INSTITUTE OF PHYSICS & CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2025-04-29 US claimed
US-12270738-B2 Fixatives and methods of use THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (MD) 2025-04-08 US claimed
WO-2025027175-A1 ELECTROLYTE ADDITIVE FOR ZN-MNO2 BATTERIES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-02-06 WO claimed
CN-119281103-A Method for capturing, storing and transporting carbon dioxide 中国科学技术大学 2025-01-10 CN claimed
EP-4437127-A1 COMPOSITIONS AND METHODS FOR NUCLEIC ACID NORMALIZATION Bioo Scientific Corporation (US) 2024-10-02 EP claimed
US-20240130956-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2024-04-25 US claimed
WO-2001053201-A1 NONABORATE COMPOSITIONS AND THEIR PREPARATION U.S. BORAX INC. (US) 2001-07-26 WO claimed
US-5763281-A ADDING PROTEIN DENATURING AGENT AND DETERGENT TO SAMPLE CONTAINING IRON, REDUCING RELEASED IRON, ADDING COLOR REAGENT, MEASURING COLOR BOEHRINGER MANNHEIM GMBH (DE) 1998-06-09 US claimed
EP-0581843-A1 BIODEGRADABLE COMPOSITIONS COMPRISING STARCH PARKE DAVIS AND COMPANY (US) 1994-02-09 EP claimed
EP-0578759-A1 BIODEGRADABLE COMPOSITIONS COMPRISING STARCH DERIVATIVES PARKE, DAVIS & COMPANY (US) 1994-01-19 EP claimed
WO-1993020141-A1 BIODEGRADABLE STARCH DERIVATIVE COMPOSITIONS PARKE-DAVIS & COMPANY (US) 1993-10-14 WO claimed
WO-1993020140-A1 BIODEGRADABLE POLYMER COMPOSITIONS PARKE-DAVIS & COMPANY (US) 1993-10-14 WO claimed
CN-1067253-A The biodegradable composition that comprises starch derivative PARKE DAVIS & CO (US) 1992-12-23 CN claimed
CN-1066077-A Biodegradable amyloid composition PARKE DAVIS & CO (US) 1992-11-11 CN claimed
WO-1992016584-A1 BIODEGRADABLE COMPOSITIONS COMPRISING STARCH PARKE, DAVIS & COMPANY (US) 1992-10-01 WO claimed
WO-1992016583-A1 BIODEGRADABLE COMPOSITIONS COMPRISING STARCH DERIVATIVES PARKE, DAVIS & COMPANY (US) 1992-10-01 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240130956-A1 HAIR COSMETIC COMPOSITION PHOSPHO1, ODC1, H1-0 BLM 4353/4885KDM4E 1056/4885CYP2C19 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.